IDO1 and obesity disorder: Collectively, our data support that the high levels of circulating Kyn in subjects affected by obesity are likely caused by the enhanced IDO1 expression, and Kyn seems acting as an agonist to promote obesity and insulin resistance rather than serving as an immune-suppressor to repress chronic inflammation in the adipose tissue.